百利天恒:拟1亿元-2亿元回购公司股份,回购价不超546元/股

Group 1 - The company plans to repurchase its shares through centralized bidding, with a total repurchase amount ranging from 100 million to 200 million yuan [1] - The maximum repurchase price is set at 546 yuan per share [1] - The repurchased shares will be used for employee stock ownership plans or equity incentives [1] Group 2 - The repurchase period is set for 12 months from the date the board of directors approves the share repurchase plan [1]

BIOKIN PHARMACEUTICAL-百利天恒:拟1亿元-2亿元回购公司股份,回购价不超546元/股 - Reportify